DASH vs PACB · P/E 76, rev $13.72B vs rev $38.4M
DoorDash, Inc. Class A Common Stock (DASH) versus Pacific Biosciences of California (PACB) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. PACB currently screens at market cap $387.1M.
Not investment advice. Open the DASH and PACB stock pages for the full models.
Not investment advice.